CFDE Data Portal | Search ZBTB17

	Label	Description
	ZBTB17 associations Collection (Entity type)	Associations for ZBTB17_associations
	ZBTB17 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	ZBTB17 Gene (Entity type)	ENSG00000116809 - zinc finger and BTB domain containing 17
	GSE238213 dopamine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 0 V 1 DOXORUBICIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE165548 gemcitabine 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE242290 3 V 2 GLUTATHIONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273 GSE216292 palbociclib 0 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE192771 2 V 3 SORAFENIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE104022 1 V 0 TAMOXIFEN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

ZBTB17 associations

Associations for ZBTB17_associations

ZBTB17 associations.tsv

A file from IDG as part of the Harmonizome project

ZBTB17

ENSG00000116809 - zinc finger and BTB domain containing 17

GSE238213 dopamine 1 v 0 human dn

A Gene Set from LINCS

GSE181517 0 V 1 DOXORUBICIN HUMAN DN

A Gene Set from LINCS

GSE165548 gemcitabine 2 v 5 human up

A Gene Set from LINCS

GSE242290 3 V 2 GLUTATHIONE HUMAN DN

A Gene Set from LINCS

GSE216273 GSE216292 palbociclib 0 v 7 human up

A Gene Set from LINCS

GSE192771 2 V 3 SORAFENIB HUMAN UP

A Gene Set from LINCS

GSE104022 1 V 0 TAMOXIFEN MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.